RELIEF THERAPEUTICS
LIVE

Serial Number

79198534

Owner

Relief Therapeutics S.A.

Attorney

Monica Riva Talley

Filing Date

Aug 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RELIEF THERAPEUTICS Trademark

Serial Number: 79198534 • Registration: 5505300

RELIEF THERAPEUTICS is a trademark filed by Relief Therapeutics S.A. on August 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Relief Therapeutics S.A.

c/o Fidraco,
Genève CH-1208 , CH

Entity Type: 99

Relief Therapeutics Holding S.A.

c/o Fidraco,

Entity Type: 99

Trademark Details

Filing Date

August 3, 2016

Registration Date

July 3, 2018

Published for Opposition

April 17, 2018

Cancellation Date

January 17, 2025

Goods & Services

Scientific and technological services, namely, scientific and pharmaceutical research, testing the efficacy, safety and tolerability of pharmaceuticals, and pharmaceutical drug development as well as new product research and design relating thereto; industrial analysis and research services in the field of pharmaceuticals, medical diagnostic preparations, and biotechnology; scientific research and development and medical research and development in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; research and development in the field of biotechnology; research in the fields of chemistry and biology; research in the field of biochemistry; scientific research for medical purposes; research and development in the field of diagnostic preparations; product development consulting; research and development of products; pharmaceutical research and development services; computer-aided scientific research, testing and analysis services in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; conducting of scientific feasibility studies; scientific analyses in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; scientific research, testing and analysis services in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; services provided by consultants in the field of scientific and industrial research, namely, research and development of new therapeutic pharmaceutical preparations; preparation of reports relating to scientific research; providing scientific research information in the form of scientific reports; provision of information and data relating to scientific and technological research and development in the field of pharmaceuticals, medical diagnostic preparations and biotechnology; providing research information and results in the fields of biotechnology, science and medicine from an on-line searchable database; pharmaceutical drug development services; pharmaceutical research and development; scientific laboratory services; scientific research services for third parties in the field of biotechnology; design and development of computer hardware and software; development and research of products for third parties; consultancy services relating to biotechnology; analysis services, namely, consulting services in the fields of biotechnology, pharmacotherapy research and development, diagnostics, and pharmaceutical research and development; pharmaceutical and biological development and research services for third parties; clinical research in the field of treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; evaluation of pharmaceutical products; research in the field of pharmaceutical products; laboratory research in the field of medicinal and analytical chemistry, biology, pharmacology and toxicology; clinical development services, namely, research and development of new therapeutic pharmaceutical preparations; none of the foregoing for clinical trials on safety and effectiveness of drugs, apremilast, drugs for Behçet's disease, or for providing medical and scientific research information in the field of clinical trials

Business consulting; project management services for others for business purposes; business consultancy services; compilation and management of computerized databases and central data files in the field of medicine; compilation of statistics; collection and systematization of data in a central file; business information, namely, provision of commercial information in the field of pharmaceutical products and provision of commercial information for consumers relating to medical and scientific research in the field of pharmaceutical products

Pharmaceutical and veterinary products, namely, prescription drugs for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; diagnostic products for medical use, namely, diagnostic preparations and reagents for the diagnosis of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; medicinal preparations and substances, namely, protein supplements, peptides from synthetic sources or extracted from natural organisms for the treatment of pulmonary affections, diabetic complications, neuropathies, allergies, and inflammation, and small chemical molecules from synthetic or natural sources for the treatment of pulmonary affections, diabetic complications, neuropathies, allergies, and inflammation ; biochemical preparations for medical or veterinary use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biological and chemical reagents for medical or veterinary use; biological preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; chemical preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biotechnological preparations for medical use, namely, for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biotechnological products for medical use, namely, prescription drugs for the treatment of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; medical diagnostic products, namely, diagnostic preparations and reagents for the diagnosis of diabetic complications, inflammatory diseases, pulmonary affections, neurological diseases, and metabolic diseases; biomarkers for medicine, namely, diagnostic biomarker reagents for medical purposes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 19, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 4, 2026 INTS
INVALIDATION PROCESSED
Mar 4, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 17, 2025 INTR
CANCELLED SECTION 71
Jan 17, 2025 C71T
REGISTERED - SEC. 7 REQUEST ABANDONED
Jun 1, 2024 PRA7
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 3, 2023 REM3
POST REGISTRATION ACTION MAILED - SEC. 7
Aug 24, 2022 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 16, 2022 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 16, 2022 ADCH
TEAS SECTION 7 REQUEST RECEIVED
Mar 22, 2022 ES7R
NEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2022 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Jan 20, 2022 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 20, 2022 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 26, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 5, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 5, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2018 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 8, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 23, 2018 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 17, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 13, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 28, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 28, 2018 OP2R
NEW REPRESENTATIVE AT IB RECEIVED
Mar 15, 2018 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 22, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 22, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 22, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 22, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2017 CNRT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2017 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2017 TROA
REFUSAL PROCESSED BY IB
Jan 27, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 29, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 28, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 27, 2016 MAFR
ASSIGNED TO EXAMINER
Dec 23, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 23, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2016 REPR